Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_assertion type Assertion NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_head.
- NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_assertion description "[Compared with NL, hepatic mRNA and protein levels of FAT/CD36 were significantly higher in patients with NAS (median fold increase 0.84 (range 0.15-1.61) and 0.66 (range 0.33-1.06), respectively); NASH (0.91 (0.22-1.81) and 0.81 (0.38-0.92), respectively); HCV G1 without steatosis (0.30 (0.17-1.59) and 0.33 (0.29-0.52), respectively); and HCV G1 with steatosis (0.85 (0.15-1.98) and 0.87 (0.52-1.26), respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_provenance.
- NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_assertion evidence source_evidence_literature NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_provenance.
- NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_assertion SIO_000772 21270117 NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_provenance.
- NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_assertion wasDerivedFrom befree-20140225 NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_provenance.
- NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_assertion wasGeneratedBy ECO_0000203 NP646533.RATJDFoDHgS0Pw_Ggda6t7mKWJIyI7G7PFoQm8EkRpbaI130_provenance.